Monopar Therapeutics Inc. Proceeds from Common Stock Issued
Monopar Therapeutics Inc. (MNPR) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-03-27
- Monopar Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Monopar Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- Monopar Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $0.00.
- Monopar Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Monopar Therapeutics Inc. proceeds from issuance of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Monopar Therapeutics Inc. proceeds from issuance of common stock for fiscal 2024 was $4.20M, a 102.60% increase from fiscal 2023.
- Monopar Therapeutics Inc. proceeds from issuance of common stock for fiscal 2023 was $2.07M, a 1797.07% increase from fiscal 2022.
- Monopar Therapeutics Inc. proceeds from issuance of common stock for fiscal 2022 was $109.34K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $1.01M derived: sum of 4 quarters · filed 2026-03-27 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $1.01M derived: sum of 3 quarters · filed 2026-03-27 | $1.01M derived: sum of 4 quarters · filed 2026-03-27 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $1.01M derived: sum of 2 quarters · filed 2026-03-27 | $1.01M derived: sum of 3 quarters · filed 2026-03-27 | $1.01M derived: sum of 4 quarters · filed 2026-03-27 | |
| 2024-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.01M derived: sum of 2 quarters · filed 2026-03-27 | $1.01M derived: sum of 3 quarters · filed 2026-03-27 | $4.20M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.00 derived: sum of 2 quarters · filed 2025-11-13 | $3.19M 10-Q · filed 2025-11-13 | $3.53M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $3.19M 10-Q · filed 2025-08-12 | $3.53M derived: sum of 3 quarters · filed 2025-08-12 | $3.79M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $3.19M 10-Q · filed 2025-05-13 | $3.53M derived: sum of 2 quarters · filed 2025-05-13 | $3.79M derived: sum of 3 quarters · filed 2025-05-13 | $4.45M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $339.87K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $594.78K derived: sum of 2 quarters · filed 2025-03-31 | $1.25M derived: sum of 3 quarters · filed 2025-03-31 | $2.07M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $254.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $912.70K derived: sum of 2 quarters · filed 2024-11-08 | $1.73M 10-Q · filed 2024-11-08 | $1.84M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $657.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.48M 10-Q · filed 2024-08-09 | $1.59M derived: sum of 3 quarters · filed 2024-08-09 | $1.59M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $821.63K 10-Q · filed 2024-05-09 | $930.96K derived: sum of 2 quarters · filed 2024-05-09 | $930.96K derived: sum of 3 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $109.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $109.34K derived: sum of 2 quarters · filed 2024-03-28 | $109.34K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | ||||
| 2021-03-31 | $10.93M 10-Q · filed 2021-05-13 | $10.93M derived: sum of 2 quarters · filed 2021-05-13 | $17.68M derived: sum of 3 quarters · filed 2021-05-13 | $18.59M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2020-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $6.75M derived: sum of 2 quarters · filed 2021-03-25 | $7.67M derived: sum of 3 quarters · filed 2021-03-25 | $8.18M 10-K · filed 2021-03-25 | |
| 2020-09-30 | $6.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $7.67M derived: sum of 2 quarters · filed 2020-11-12 | $8.18M 10-Q · filed 2020-11-12 | $8.18M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2020-06-30 | $913.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.42M 10-Q · filed 2020-08-06 | $1.42M derived: sum of 3 quarters · filed 2021-05-13 | $1.42M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2020-03-31 | $508.04K 10-Q · filed 2021-05-13 | $542.43K 10-Q · filed 2020-05-07 | $508.04K derived: sum of 2 quarters · filed 2021-05-13 | $508.04K derived: sum of 3 quarters · filed 2021-05-13 | $508.04K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-08-06 | $0.00 derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-05-07 | $0.00 derived: sum of 3 quarters · filed 2020-05-07 | $0.00 derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | $10.00K derived: sum of 4 quarters · filed 2019-02-26 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $10.00K derived: sum of 3 quarters · filed 2019-02-26 | $2.68M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | $10.00K derived: sum of 2 quarters · filed 2019-02-26 | $2.68M derived: sum of 3 quarters · filed 2019-02-26 | $3.72M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $2.68M derived: sum of 2 quarters · filed 2019-02-26 | $3.72M derived: sum of 3 quarters · filed 2019-02-26 | $4.71M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $3.71M derived: sum of 2 quarters · filed 2018-11-09 | $4.70M 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.03M 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | $990.00K 10-Q · filed 2018-05-11 | ||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |